PDL BioPharma, Inc. Treasury Stock

Treasury Stock of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Treasury Stock growth rates and interactive chart.

Highlights and Quick Summary

  • Treasury Stock for the quarter ending March 30, 2020 was $2.24 Million (a 310.99% increase compared to previous quarter)
  • Year-over-year quarterly Treasury Stock increased by 6.7%
  • Annual Treasury Stock for 2018 was $2.1 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Treasury Stock of PDL BioPharma, Inc.

Most recent Treasury Stockof PDLI including historical data for past 10 years.

Interactive Chart of Treasury Stock of PDL BioPharma, Inc.

PDL BioPharma, Inc. Treasury Stock for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $2.24
2019 $0.55 $1.49
2018 $2.1 $1.19 $2.1
2017 $1.31

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.